Ausgabe 4/2013
Inhalt (10 Artikel)
Innovative potential treatment strategies for schizophrenia and biomarkers for Alzheimer’s disease
Andrea Schmitt, Peter Falkai
Epigenetic dysregulation in schizophrenia: molecular and clinical aspects of histone deacetylase inhibitors
Alkomiet Hasan, Amanda Mitchell, Anja Schneider, Tobias Halene, Schahram Akbarian
Aripiprazole differentially regulates the expression of Gad67 and γ-aminobutyric acid transporters in rat brain
Nina Peselmann, Andrea Schmitt, Peter J. Gebicke-Haerter, Mathias Zink
Insight in schizophrenia: associations with empathy
G. H. M. Pijnenborg, J. M. Spikman, B. F. Jeronimus, A. Aleman
High rehospitalization rate in alcohol-induced psychotic disorder
Michael Soyka, Bernd Helten, Marcus Cleves, Peggy Schmidt
Brain perfusion asymmetry in patients with oral somatic delusions
Yojiro Umezaki, Ayano Katagiri, Motoko Watanabe, Miho Takenoshita, Tomomi Sakuma, Emi Sako, Yusuke Sato, Akira Toriihara, Akihito Uezato, Hitoshi Shibuya, Toru Nishikawa, Haruhiko Motomura, Akira Toyofuku
The National Institute on Aging-Alzheimer’s Association research criteria for mild cognitive impairment due to Alzheimer’s disease: predicting the outcome
Liang-Hao Guo, Panagiotis Alexopoulos, Tamara Eisele, Stefan Wagenpfeil, Alexander Kurz, Robert Perneczky
Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer’s disease
Sönke Arlt, Ralph Buchert, Lothar Spies, Martin Eichenlaub, Jan T. Lehmbeck, Holger Jahn
Increased 3-Hydroxykynurenine serum concentrations differentiate Alzheimer’s disease patients from controls
Markus J. Schwarz, Gilles J. Guillemin, Stefan J. Teipel, Katharina Buerger, Harald Hampel
The psychiatric interview: validity, structure, and subjectivity
Julie Nordgaard, Louis A. Sass, Josef Parnas